Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

EyePoint Pharmaceuticals (EYPT) Operating Expenses: 2010-2018

Historic Operating Expenses for EyePoint Pharmaceuticals (EYPT) over the last 8 years, with Sep 2018 value amounting to $14.0 million.

  • EyePoint Pharmaceuticals' Operating Expenses rose 119.68% to $14.0 million in Q3 2018 from the same period last year, while for Sep 2018 it was $36.9 million, marking a year-over-year increase of 47.28%. This contributed to the annual value of $29.2 million for FY2018, which is 11.95% up from last year.
  • As of Q3 2018, EyePoint Pharmaceuticals' Operating Expenses stood at $14.0 million, which was up 33.75% from $10.5 million recorded in Q2 2018.
  • Over the past 5 years, EyePoint Pharmaceuticals' Operating Expenses peaked at $14.0 million during Q3 2018, and registered a low of $4.2 million during Q1 2014.
  • In the last 3 years, EyePoint Pharmaceuticals' Operating Expenses had a median value of $6.7 million in 2017 and averaged $7.4 million.
  • Its Operating Expenses has fluctuated over the past 5 years, first dropped by 14.36% in 2017, then surged by 119.68% in 2018.
  • EyePoint Pharmaceuticals' Operating Expenses (Quarterly) stood at $4.6 million in 2014, then rose by 24.30% to $5.8 million in 2015, then increased by 5.22% to $6.1 million in 2016, then climbed by 11.15% to $6.7 million in 2017, then surged by 119.68% to $14.0 million in 2018.
  • Its last three reported values are $14.0 million in Q3 2018, $10.5 million for Q2 2018, and $5.6 million during Q1 2018.